ISMRM22 - Musculoskeletal Imaging: Optimal MR Imaging for Musculoskeletal Tumors

Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting • 07-12 May 2022 • London, UK

Musculoskeletal Imaging: Optimal MR Imaging for Musculoskeletal Tumors

Sunrise Course

ORGANIZERS: Kimberly Amrami, Hiroshi Yoshioka

Tuesday, 10 May 2022

ICC Capital Suite 7 & 12

08:00 - 09:00

Moderators: Benjamin Howe

Skill Level: Intermediate to Advanced

Session Number: S-Tu-04

Session Number: S-Tu-04

Overview
The Sunrise Sessions for MSK will present the latest techniques for evolving areas of clinical applications for MSK MRI. The topics presented will include MR Imaging in the Presence of Metal, Optimal MR Imaging for MSK Tumors, UTE/ZTE for MSK Applications and Value-Based MSK MR Imaging. Each subsection will include paired technical and clinical talks with emphasis on clinical translation of the most up to date techniques for MSK MR.

Target Audience
Clinicians, physicists, engineers, and trainees.

Educational Objectives
As a result of attending this course, participants should be able to:
- Explain techniques and applications of MSK MRI in the presence of metal, including advanced technical and clinical approaches to patients with metallic implants;
- Dissect the definition of "value-based" MRI for MSK applications including pitfalls and opportunities for optimizing imaging;
- Describe evolving uses for ZTE/UTE for MSK MRI and how to translate these techniques to clinical practice; and
- List novel options for MR imaging for MSK tumors, including quantitative techniques such as perfusion and diffusion.

	08:00		Optimal MR Imaging for Musculoskeletal Tumors: Technical Considerations View the Presentation Kai Vilanova A comprehensive tumor imaging protocol should provide the optimal anatomic and functional information within the different sequences. It requires to include conventional pulse sequences (T1-weighted and fluid-sensitive sequences: fat-suppressed T2 weighted or STIR) with functional ones such as chemical shift MR imaging (in-phase and opposed-phase imaging/Dixon), diffusion-weighted imaging, perfusion (time resolved MRI) and/or spectroscopy. Each sequence should be performed properly to provide the different and additional information for the assessment of a musculoskeletal lesion: detection-diagnosis, characterization, determination of extent, or the posttreatment setting for recurrence and treatment response.
	08:30		Optimal MR Imaging for Musculoskeletal Tumors: Clinical Considerations View the Presentation Amanda Isaac